Comments
Loading...

Axsome Therapeutics Earnings Estimates

AXSMNASDAQ
Logo brought to you by Benzinga Data
$131.33
3.792.97%

Axsome Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AXSM | Benzinga

Axsome Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 5
EPS Estimate
$-0.870
Quarterly Revenue Estimate
$121.46M
Annual Revenue
(as of Dec 31)
$385.69M

Analyze the earnings history of Axsome Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Axsome Therapeutics (AXSM) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q42025-02-18$-0.80$-0.9919.2 %
Q32024-11-12$-0.49$-1.4165.3 %
Q22024-08-05$-1.12$-1.3315.8 %
Q12024-05-06$-1.00$-1.2117.4 %

Axsome Therapeutics (AXSM) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q42025-02-18$118.77M$117.83M0.79 %
Q32024-11-12$104.76M$98.10M6.79 %
Q22024-08-05$87.17M$86.92M0.28 %
Q12024-05-06$75.00M$73.47M2.08 %

FAQ

Q

When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?

A

Axsome Therapeutics (AXSM) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 18, 2025 for Q4.

Q

What were the latest earnings per share (EPS) for Axsome Therapeutics (NASDAQ:AXSM)?

A

The Actual EPS was $-0.80, which beat the estimate of $-0.99.

Q

What were Axsome Therapeutics’s (NASDAQ:AXSM) revenues?

A

The Actual Revenue was $118.8M, which beat the estimate of $117.8M.

Browse earnings estimates, EPS, and revenue on all stocks.